Participants between the ages of 10–86 years old were vaccinated with split-inactivated influenza vaccine (Fluzone®) in six consecutive influenza seasons from 2016–2017 to 2021–2022. Vaccine effective
*Infectivity controls. **NAb = neutralizing antibody titers for Ad5 (provided only for the 11 volunteers included in the immunogenicity and efficacy analysis).
